UBRO YELLOW®
IS BACK. And there’s still work to do.
With bovine mastitis making a resurgence in recent years,1 and the disease now costing the UK dairy industry millions, the return of Ubro Yellow will be helpful to many dairy farmers working with their vets. Given its broad spectrum of activity and considerable history of on-farm success, Ubro Yellow still has a contribution to make. When you’re next discussing mastitis diagnosis, treatment options and whole-herd management strategies, your vet may recommend incorporating Ubro Yellow into a treatment plan that’s right for you.
Reference: 1. www.dairyco.net/farming-info-centre/health-welfare/mastitis.aspx Advice on the use of Ubro Yellow or other therapies should be sought from your veterinary surgeon. Ubro Yellow contains penethamate hydriodide, dihydrostreptomycin sulphate, framycetin sulphate and prednisolone. Prescription only medicine. Withdraw milk from supply for human consumption for 132 hours after the last Ubro Yellow treatment. Further information available from Boehringer Ingelheim Vetmedica, Bracknell, Berkshire, RG12 8YS, UK. Email: vetmedica.uk@boehringer-ingelheim.com. Date of preparation: Jul 2011. AHD6809. The advertisement is brought to you by Boehringer Ingelheim, manufacturers of Ubro Yellow. Use Medicines Responsibly (www.noah.co.uk/responsible)
www.mastitis.co.uk/ubroyellow
23183 Farmer SPS_v4.indd 1 CM06_p60.indd 60
14/07/2011 14:25 25-08-2011 13:37:17